dismiss

Get a Free 3-Day Pass to AAMI 2014 in Philadelphia, May 31-June 2 -- Visit DOTmed, Booth 231

SEARCH

Current Location: DOTmed News > Industry Headlines > This Story

(1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

 

More Industry Headlines

Doc fix bill puts clinical decision support in the spotlight Appropriateness criteria is the new reality.

False positive results: not as bad as you thought But women will still undergo additional breast cancer tests.

ECRI's top 10 patient safety concerns HIT, care coordination, drug shortages top safety list.

FDA clears new CT system from Siemens Ideal for challenging cases.

FDA OKs Shimadzu's new R/F system For a wide variety of exams.

Gov. Jan Brewer signs breast density law Arizona becomes the latest state with inform legislation.

CT can detect arterial plaque for diabetics CCTA is a welcome development.

Goggles that illuminate cancer cells Could they reduce second surgeries?

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

Regenerative medicine
to generate sales

Regenerative Medicine to Be a $20 Billion Industry by 2025

by Brendon Nafziger , DOTmed News Associate Editor
Explosive growth over the next decade in the field of regenerative medicine could aid medical device companies looking to develop "delivery systems" for cell therapies, according to an analysis released last week.

The market for technologies that repair the body now stands at $1.6 billion, but could swell to $15-20 billion over the next 15 years, says Arshad Ahmed, partner of Scientia Advisors, a biotech and medical consulting firm, in a global market review.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250



While regenerative medicine conjures up mad-science images of growing batches of new organs or limbs - or even the infamous mouse with a human ear blooming on its back - the main focus of "regen" in the short-term will be on practical, specific clinical applications, Ahmed tells DOTmed News.

What these therapies might lack in sci-fi glamor, they make up for in potential clinical benefits to patients and time-saving in physicians' workflows.

For instance, currently, half of the revenues of regen comes from spine fusion applications, such as those supplied by Medtronic, says Ahmed.

These involve bone morphogenetic protein, or BMP, genetically modified human proteins that spur bone growth. It's delivered in a sponge or gel, and helps vertebrae fuse back together after certain kinds of spine surgeries.

Ahmed believes that BMP is a good model for future successful regen products, because it makes doctors' "workflow much simpler than the existing standard of care," he says.

BMP is only approved for some kinds of spinal fusion surgeries and a study last year suggested it was associated with a higher rate of complications. Still, Ahmed points out that it has been widely adopted by surgeons, because it has the potential to make "life much easier" by reducing the number of procedures performed in a back surgery.

For surgeries where doctors can use BMP, they can forgo the usual first step of removing a piece of the patient's hip bone, which they then have to grind to a powder and then re-inject into the patient's spinal cage during the surgery, to encourage healing - a role now taken over by BMP.

"The procedure is simpler and it takes less time for surgeons to do it, so they can see more patients," he says.

Patients like it, too, he notes, as they're spared an extra surgical step.

VASCULAR GROWTH

Over the short-term, Ahmed expects much of the new growth to be in peripheral vascular applications, where regen is helping the body repair damage to the vascular system.

One promising treatment possibly not too far from the clinic is being developed by Pervasis.

Continue reading Regenerative Medicine to Be a $20 Billion Industry by 2025...
  Pages: 1 - 2 - 3 >>

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED